Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37064086 | PubTator, text mining | PubMed |
| Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity. | Front Immunol | 2023 | 37063898 | PubTator, text mining | PubMed |
| A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells. | Front Immunol | 2023 | 37063842 | PubTator, text mining | PubMed |
| Advances in the multi-omics landscape of follicular lymphoma. | Int J Biol Sci | 2023 | 37063433 | PubTator, text mining | PubMed |
| Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer. | Clin Epigenetics | 2023 | 37061743 | PubTator, text mining | PubMed |
| Cellular senescence-related gene signature as a valuable predictor of prognosis in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37059592 | PubTator, text mining | PubMed |
| Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. | Front Immunol | 2023 | 37056774 | PubTator, text mining | PubMed |
| Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point? | Front Oncol | 2023 | 37056346 | PubTator, text mining | PubMed |
| Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily. | Front Immunol | 2023 | 37051245 | PubTator, text mining | PubMed |
| POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 37047824 | PubTator, text mining | PubMed |
| The Regulatory Axis of PD-L1 Isoform 2/TNF/T Cell Proliferation Is Required for the Canonical Immune-Suppressive Effects of PD-L1 Isoform 1 in Liver Cancer. | Int J Mol Sci | 2023 | 37047287 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer. | Aging (Albany NY) | 2023 | 37036489 | PubTator, text mining | PubMed |
| T Cell Subsets and the Expression of Related MicroRNAs in Patients with Recurrent Early Pregnancy Loss. | Mediators Inflamm | 2023 | 37035756 | PubTator, text mining | PubMed |
| Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies. | Front Immunol | 2023 | 37033968 | PubTator, text mining | PubMed |
| FLAN: feature-wise latent additive neural models for biological applications. | Brief Bioinform | 2023 | 37031956 | PubTator, text mining | PubMed |
| Cross-platform dataset of multiplex fluorescent cellular object image annotations. | Sci Data | 2023 | 37029126 | PubTator, text mining | PubMed |
| Human T follicular helper clones seed the germinal center-resident regulatory pool. | Sci Immunol | 2023 | 37027481 | PubTator, text mining | PubMed |
| The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy. | Mol Cancer | 2023 | 37024932 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. | Nat Commun | 2023 | 37024479 | PubTator, text mining | PubMed |
| Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues. | Front Immunol | 2023 | 37020558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=30